Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Bone Regulates Browning and Energy Metabolism Through Mature Osteoblast/Osteocyte PPARγ Expression.

Brun J, Berthou F, Trajkovski M, Maechler P, Foti M, Bonnet N.

Diabetes. 2017 Oct;66(10):2541-2554. doi: 10.2337/db17-0116. Epub 2017 Jul 7.

2.

The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.

Berthou F, Ceppo F, Dumas K, Massa F, Vergoni B, Alemany S, Cormont M, Tanti JF.

Mol Endocrinol. 2015 Jul;29(7):1025-36. Epub 2015 May 28.

3.

[Implication of MAP kinases in obesity-induced inflammation and insulin resistance].

Ceppo F, Jager J, Berthou F, Giorgetti-Peraldi S, Cormont M, Bost F, Tanti JF.

Biol Aujourdhui. 2014;208(2):97-107. doi: 10.1051/jbio/2014014. Epub 2014 Sep 8. Review. French.

PMID:
25190570
4.

Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages.

Ceppo F, Berthou F, Jager J, Dumas K, Cormont M, Tanti JF.

Endocrinology. 2014 Mar;155(3):951-64. doi: 10.1210/en.2013-1815. Epub 2014 Jan 1.

PMID:
24424060
5.

Implication of inflammatory signaling pathways in obesity-induced insulin resistance.

Tanti JF, Ceppo F, Jager J, Berthou F.

Front Endocrinol (Lausanne). 2013 Jan 8;3:181. doi: 10.3389/fendo.2012.00181. eCollection 2012.

6.

Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity.

Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, Fritsche A, Lievertz PS, Gertler A, Berthou F, Taouis M, Staiger H, Häring HU, Hennige AM.

Cell Physiol Biochem. 2012;30(1):238-46. doi: 10.1159/000339060. Epub 2012 Jun 19.

7.

Hypothalamic serotonin-insulin signaling cross-talk and alterations in a type 2 diabetic model.

Papazoglou I, Berthou F, Vicaire N, Rouch C, Markaki EM, Bailbe D, Portha B, Taouis M, Gerozissis K.

Mol Cell Endocrinol. 2012 Mar 5;350(1):136-44. doi: 10.1016/j.mce.2011.12.007. Epub 2011 Dec 19.

PMID:
22209745
8.

Chronic central leptin infusion differently modulates brain and liver insulin signaling.

Berthou F, Rouch C, Gertler A, Gerozissis K, Taouis M.

Mol Cell Endocrinol. 2011 Apr 30;337(1-2):89-95. doi: 10.1016/j.mce.2011.02.005. Epub 2011 Feb 12.

PMID:
21320568
9.

Leptin but not ciliary neurotrophic factor (CNTF) induces phosphotyrosine phosphatase-1B expression in human neuronal cells (SH-SY5Y): putative explanation of CNTF efficacy in leptin-resistant state.

Benomar Y, Berthou F, Vacher CM, Bailleux V, Gertler A, Djiane J, Taouis M.

Endocrinology. 2009 Mar;150(3):1182-91. doi: 10.1210/en.2008-1097. Epub 2008 Nov 13.

PMID:
19008309
10.

Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode.

Goulitquer S, Dréano Y, Berthou F, Corcos L, Lucas D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 1;876(1):83-8. doi: 10.1016/j.jchromb.2008.10.035. Epub 2008 Oct 28.

PMID:
19004672
11.

Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism.

Fer M, Corcos L, Dréano Y, Plée-Gautier E, Salaün JP, Berthou F, Amet Y.

J Lipid Res. 2008 Nov;49(11):2379-89. doi: 10.1194/jlr.M800199-JLR200. Epub 2008 Jun 24.

12.

Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.

Fer M, Dréano Y, Lucas D, Corcos L, Salaün JP, Berthou F, Amet Y.

Arch Biochem Biophys. 2008 Mar 15;471(2):116-25. doi: 10.1016/j.abb.2008.01.002. Epub 2008 Jan 11.

PMID:
18206980
13.

Determination of polyunsaturated fatty acid monoepoxides by high performance liquid chromatography-mass spectrometry.

Fer M, Goulitquer S, Dréano Y, Berthou F, Corcos L, Amet Y.

J Chromatogr A. 2006 May 19;1115(1-2):1-7. Epub 2006 Mar 20.

PMID:
16545829
14.

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.

Piver B, Fer M, Vitrac X, Merillon JM, Dreano Y, Berthou F, Lucas D.

Biochem Pharmacol. 2004 Aug 15;68(4):773-82.

PMID:
15276085
16.

CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes.

González-Jasso E, López T, Lucas D, Berthou F, Manno M, Ortega A, Albores A.

Toxicol Lett. 2003 Sep 15;144(1):55-67.

PMID:
12919724
17.

Influence of genetic polymorphisms of CYP1A1 and GSTM1 on the urinary levels of 1-hydroxypyrene.

Apostoli P, Neri G, Lucas D, Manno M, Berthou F.

Toxicol Lett. 2003 Sep 15;144(1):27-34.

PMID:
12919721
18.

Susceptibility and exposure biomarkers in people exposed to PAHs from diesel exhaust.

Adonis M, Martínez V, Riquelme R, Ancic P, González G, Tapia R, Castro M, Lucas D, Berthou F, Gil L.

Toxicol Lett. 2003 Sep 15;144(1):3-15.

PMID:
12919719
19.

Biodistribution study of phosphonolipids: a class of non-viral vectors efficient in mice lung-directed gene transfer.

Delépine P, Guillaume C, Montier T, Clément JC, Yaouanc JJ, Des Abbayes H, Berthou F, Le Pape A, Férec C.

J Gene Med. 2003 Jul;5(7):600-8.

PMID:
12825199
21.

Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1 R and ecNOS.

Basset el-EA, Berthoux P, Cécillon S, Deprle C, Thibaudin D, De Filippis JP, Alamartin E, Berthou F.

Clin Nephrol. 2002 Mar;57(3):192-200.

PMID:
11926202
22.

[Alcohol-xenobiotic interactions. Role of cytochrome P450 2E1].

Meskar A, Plee-Gautier E, Amet Y, Berthou F, Lucas D.

Pathol Biol (Paris). 2001 Nov;49(9):696-702. Review. French.

PMID:
11762131
23.

Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components.

Piver B, Berthou F, Dreano Y, Lucas D.

Toxicol Lett. 2001 Dec 15;125(1-3):83-91.

PMID:
11701226
24.
25.

Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments.

Lucas D, Ferrara R, Gonzales E, Albores A, Manno M, Berthou F.

Toxicol Lett. 2001 Oct 15;124(1-3):71-81. Review.

PMID:
11684359
26.

Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels.

Le Gal A, Dréano Y, Gervasi PG, Berthou F.

Toxicol Lett. 2001 Oct 15;124(1-3):47-58. Review.

PMID:
11684357
27.

CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.

Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera AM, Gil L.

Cancer Lett. 2001 Dec 10;174(1):35-44.

PMID:
11675150
28.

Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.

Plee-Gautier E, Foresto F, Ferrara R, Bodénez P, Simon B, Manno M, Berthou F, Lucas D.

Alcohol Clin Exp Res. 2001 Jun;25(6):800-4.

PMID:
11410713
29.

Adaptation to chronic ethanol administration emphasized by fatty acid hydroxylations in rat liver and kidney microsomes.

Amet Y, Plée-Gautier E, Berthou F, Adas F, French SW.

Eur J Nutr. 2000 Dec;39(6):270-6.

PMID:
11395987
30.

Cytochrome P-450 2E1 activity and oxidative stress in alcoholic patients.

Dupont I, Bodénez P, Berthou F, Simon B, Bardou LG, Lucas D.

Alcohol Alcohol. 2000 Jan;35(1):98-103.

PMID:
10684785
31.

Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11.

Adas F, Salaün JP, Berthou F, Picart D, Simon B, Amet Y.

J Lipid Res. 1999 Nov;40(11):1990-7.

32.

Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A.

Adas F, Berthou F, Salaün JP, Dréano Y, Amet Y.

Toxicol Lett. 1999 Oct 29;110(1-2):43-55.

PMID:
10593594
33.

Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.

Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F.

Pharmacogenetics. 1999 Jun;9(3):377-88.

PMID:
10471070
34.

Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations.

Quiñones L, Berthou F, Varela N, Simon B, Gil L, Lucas D.

Cancer Lett. 1999 Jul 1;141(1-2):167-71.

PMID:
10454258
35.

Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.

Dupont I, Berthou F, Bodenez P, Bardou L, Guirriec C, Stephan N, Dreano Y, Lucas D.

Drug Metab Dispos. 1999 Mar;27(3):322-6.

PMID:
10064561
36.

Effects of interferon-alpha on cytochrome P-450 isoforms 1A2 and 3A activities in patients with chronic hepatitis C.

Pageaux GP, le Bricquir Y, Berthou F, Bressot N, Picot MC, Blanc F, Michel H, Larrey D.

Eur J Gastroenterol Hepatol. 1998 Jun;10(6):491-5.

PMID:
9855065
37.
38.

Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes.

Adas F, Berthou F, Picart D, Lozac'h P, Beaugé F, Amet Y.

J Lipid Res. 1998 Jun;39(6):1210-9.

40.

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.

Iribarne C, Picart D, Dréano Y, Berthou F.

Fundam Clin Pharmacol. 1998;12(2):194-9.

PMID:
9565774
41.

Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.

Iribarne C, Berthou F, Carlhant D, Dreano Y, Picart D, Lohezic F, Riche C.

Drug Metab Dispos. 1998 Mar;26(3):257-60.

PMID:
9492389
42.

Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.

Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D, Berthou F.

Chem Res Toxicol. 1997 Oct;10(10):1205-12.

PMID:
9348445
43.

Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes.

Amet Y, Zerilli A, Goasduff T, Dréano Y, Berthou F.

Biochem Pharmacol. 1997 Oct 15;54(8):947-52.

PMID:
9354595
44.

Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes.

Bellec G, Dréano Y, Bail JP, Ménez JF, Berthou F.

Mutat Res. 1997 Jul 3;377(2):199-209.

PMID:
9247615
45.

Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.

Langouët S, Mahéo K, Berthou F, Morel F, Lagadic-Gossman D, Glaise D, Coles B, Ketterer B, Guillouzo A.

Carcinogenesis. 1997 Jul;18(7):1343-9.

PMID:
9230277
46.

Cytochrome P450 4A and 2E1 expression in human kidney microsomes.

Amet Y, Berthou F, Fournier G, Dréano Y, Bardou L, Clèdes J, Ménez JF.

Biochem Pharmacol. 1997 Mar 21;53(6):765-71. Erratum in: Biochem Pharmacol 1997 Jun 15;53(12):1946.

PMID:
9113097
47.

Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.

Iribarne C, Dréano Y, Bardou LG, Ménez JF, Berthou F.

Toxicology. 1997 Feb 14;117(1):13-23.

PMID:
9020195
48.

Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes.

Iribarne C, Picart D, Dréano Y, Bail JP, Berthou F.

Life Sci. 1997;60(22):1953-64.

PMID:
9180349
49.

Induction of liver and kidney CYP1A1/1A2 by caffeine in rat.

Goasduff T, Dréano Y, Guillois B, Ménez JF, Berthou F.

Biochem Pharmacol. 1996 Dec 24;52(12):1915-9.

PMID:
8951351
50.

Hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by rat liver microsomes.

Bellec G, Dreano Y, Pichon R, Ménez JF, Berthou F.

Cancer Lett. 1996 Nov 29;108(2):171-8.

PMID:
8973591

Supplemental Content

Loading ...
Support Center